Masuda T - Search Results

1

Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.

Wada K, Maesawa C, Akasaka T, Masuda T. Wada K, et al. Among authors: masuda t. J Invest Dermatol. 2004 Mar;122(3):805-11. doi: 10.1111/j.0022-202X.2004.22308.x. J Invest Dermatol. 2004. PMID: 15086568 Free article.

2

Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.

Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T. Akiyama Y, et al. Among authors: masuda t. Am J Pathol. 2003 Nov;163(5):1911-9. doi: 10.1016/S0002-9440(10)63549-3. Am J Pathol. 2003. PMID: 14578190 Free PMC article.

3

Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.

Ogasawara S, Maesawa C, Yamamoto M, Akiyama Y, Wada K, Fujisawa K, Higuchi T, Tomisawa Y, Sato N, Endo S, Saito K, Masuda T. Ogasawara S, et al. Among authors: masuda t. Oncogene. 2004 Feb 5;23(5):1117-24. doi: 10.1038/sj.onc.1207211. Oncogene. 2004. PMID: 14743202

4

Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma.

Akiyama Y, Maesawa C, Wada K, Fujisawa K, Itabashi T, Noda Y, Honda T, Sato N, Ishida K, Takagane A, Saito K, Masuda T. Akiyama Y, et al. Among authors: masuda t. Oncol Rep. 2004 Apr;11(4):871-4. Oncol Rep. 2004. PMID: 15010887

5

Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas.

Fujisawa K, Maesawa C, Sato R, Wada K, Ogasawara S, Akiyama Y, Takeda M, Fujita T, Otsuka K, Higuchi T, Suzuki K, Saito K, Masuda T. Fujisawa K, et al. Among authors: masuda t. Lab Invest. 2005 Feb;85(2):214-24. doi: 10.1038/labinvest.3700214. Lab Invest. 2005. PMID: 15608662 Free article.

6

Aberrant maspin expression in human endometrial cancer.

Murai S, Maesawa C, Masuda T, Sugiyama T. Murai S, et al. Among authors: masuda t. Cancer Sci. 2006 Sep;97(9):883-8. doi: 10.1111/j.1349-7006.2006.00266.x. Epub 2006 Jul 4. Cancer Sci. 2006. PMID: 16822296 Free PMC article.

7

Methylation status of the SOCS3 gene in human malignant melanomas.

Tokita T, Maesawa C, Kimura T, Kotani K, Takahashi K, Akasaka T, Masuda T. Tokita T, et al. Among authors: masuda t. Int J Oncol. 2007 Mar;30(3):689-94. Int J Oncol. 2007. PMID: 17273770

8

Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.

Izutsu N, Maesawa C, Shibazaki M, Oikawa H, Shoji T, Sugiyama T, Masuda T. Izutsu N, et al. Among authors: masuda t. Int J Oncol. 2008 Jun;32(6):1227-35. doi: 10.3892/ijo_32_6_1227. Int J Oncol. 2008. PMID: 18497984

9

Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells.

Akasaka K, Maesawa C, Shibazaki M, Maeda F, Takahashi K, Akasaka T, Masuda T. Akasaka K, et al. Among authors: masuda t. J Invest Dermatol. 2009 Jun;129(6):1516-26. doi: 10.1038/jid.2008.406. Epub 2009 Jan 1. J Invest Dermatol. 2009. PMID: 19122647 Free article.

10

DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer.

Kato K, Maesawa C, Itabashi T, Fujisawa K, Otsuka K, Kanno S, Tada H, Tatemichi Y, Kotani K, Oikawa H, Sugai T, Wakabayashi G, Masuda T. Kato K, et al. Among authors: masuda t. Int J Oncol. 2009 Sep;35(3):467-76. doi: 10.3892/ijo_00000358. Int J Oncol. 2009. PMID: 19639167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,395 results

Search Page

Filters